ImageneBio, Inc. (IMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $43.22M
Last updated: Nov 17, 2026 at 11:03 AM ET
ImageneBio, Inc. (IMA) Earnings: Report Dates and Results
ImageneBio (IMA) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, ImageneBio reported EPS of -$0.91, below the -$0.83 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IMA has an expected report date of Mar 1, 2027.
Earnings History
Of the 22 quarters below that had an estimate, IMA beat 7, missed 5 and matched 10. The widest gap in the table came in the quarter ended Jun 30, 2025, when EPS landed 386.94% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.91 | -$0.83 | -$0.98 - -$0.72 | -9.64% | Miss | N/A | 3 | 2 up, 0 down | Nov 9, 2026 | N/A |
| Jun 30, 2026 | -$0.63 | -$0.90 | -$1.23 - -$0.72 | +30.00% | Beat | N/A | 3 | 1 up, 1 down | Jul 23, 2026 | N/A |
| Mar 31, 2026 | -$0.95 | -$0.66 | -$0.66 - -$0.66 | -43.94% | Miss | N/A | 1 | 0 up, 0 down | May 7, 2026 | N/A |
| Dec 31, 2025 | -$0.62 | -$1.15 | N/A | +46.28% | Beat | N/A | 1 | 0 up, 0 down | Mar 10, 2026 | $800000 |
| Sep 30, 2025 | -$2.91 | -$1.00 | -$1.00 - -$1.00 | -191.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2025 | N/A |
| Jun 30, 2025 | -$0.69 | -$0.14 | N/A | -386.94% | Miss | N/A | N/A | N/A | Jul 24, 2025 | N/A |
| Mar 31, 2025 | -$0.17 | -$0.19 | N/A | +11.41% | Beat | N/A | N/A | N/A | May 8, 2025 | $800000 |
| Dec 31, 2024 | -$0.20 | -$0.21 | N/A | +3.24% | Beat | N/A | N/A | N/A | Mar 6, 2025 | N/A |
| Sep 30, 2024 | -$0.21 | -$0.25 | N/A | +17.61% | Beat | N/A | N/A | N/A | Nov 7, 2024 | $3.50M |
| Jun 30, 2024 | -$0.28 | -$0.36 | N/A | +22.22% | Beat | N/A | N/A | N/A | Aug 8, 2024 | N/A |
| Mar 31, 2024 | -$0.33 | -$0.33 | N/A | 0.00% | In line | N/A | N/A | N/A | May 13, 2024 | N/A |
| Dec 31, 2023 | -$0.41 | -$0.41 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 12, 2024 | $658000 |
| Sep 30, 2023 | -$0.40 | -$0.40 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 9, 2023 | $1.19M |
| Jun 30, 2023 | -$0.44 | -$0.44 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 10, 2023 | $2.00M |
| Mar 31, 2023 | -$0.39 | -$0.39 | N/A | 0.00% | In line | N/A | N/A | N/A | May 15, 2023 | $5.31M |
| Dec 31, 2022 | -$0.39 | -$0.39 | N/A | 0.00% | In line | -657.1% | N/A | N/A | Mar 14, 2023 | $5.45M |
| Sep 30, 2022 | -$0.48 | -$0.48 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 7, 2022 | $6.40M |
| Jun 30, 2022 | -$0.57 | -$0.57 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 11, 2022 | $382000 |
| Mar 31, 2022 | -$0.47 | -$0.47 | N/A | 0.00% | In line | N/A | N/A | N/A | May 12, 2022 | $3.38M |
| Dec 31, 2021 | $0.07 | $0.07 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 17, 2022 | $20.22M |
| Sep 30, 2021 | -$0.40 | -$0.42 | N/A | +4.76% | Beat | N/A | N/A | N/A | Nov 10, 2021 | $3.75M |
| Jun 30, 2021 | -$1.89 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2021 | $3.55M |
| Mar 31, 2021 | -$2.52 | -$0.87 | N/A | -189.22% | Miss | N/A | N/A | N/A | May 13, 2021 | $3.47M |
| Dec 31, 2020 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 26, 2021 | $65000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.39, after -$1.02 the year before. It was -$0.15 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.39 | N/A |
| Dec 31, 2024 | -$1.02 | N/A |
| Dec 31, 2023 | -$1.64 | N/A |
| Dec 31, 2022 | -$1.91 | N/A |
| Dec 31, 2021 | -$4.74 | N/A |
| Dec 31, 2020 | -$0.15 | N/A |
Frequently Asked Questions About IMA
When is ImageneBio's next earnings date?
ImageneBio's next earnings report is expected for Mar 1, 2027.
Did IMA beat earnings estimates last quarter?
No. ImageneBio reported EPS of -$0.91 for the quarter ended Sep 30, 2026, below the -$0.83 estimate by 9.64%.
What EPS do analysts expect from IMA next quarter?
The consensus EPS estimate for ImageneBio for the quarter ending Dec 31, 2026 is -$0.97 from 5 analysts, with estimates from -$1.00 to -$0.96.
How often does IMA beat earnings estimates?
ImageneBio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -67.57%.
IMA pages: Overview, Earnings, Forecast, Financials, Competitors